Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00032994 · ClinicalTrials.gov registry record · Phase 3

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

A Phase 3 study, sponsored by Yale University.

Completed
Registry status
Phase 3
Development phase
422
Enrollment target

NCT00032994: Completed Phase 3 study, sponsored by Yale University.

NCT00032994 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 422 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00032994, a Phase 3 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 3
Development phase
422 participants
Enrollment target

Study Summary

The purpose of this study is to assess Motivational Interviewing (MI) to improve treatment engagement and outcome in subjects seeking treatment for substance abuse.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 422 participants
Start Date 2001-04
Est. Completion 2002-10
Phase Phase 3
Yale University

1,492 total trials

What the finished NCT00032994 record still lists

NCT00032994 is an interventional study that assigns participants to a tested intervention. The registered 422 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00032994 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00032994 about?

NCT00032994 is a clinical study titled "Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1". The purpose of this study is to assess Motivational Interviewing (MI) to improve treatment engagement and outcome in subjects seeking treatment for substance abuse.

What is the current status of trial NCT00032994?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 422 participants. The study started on 2001-04. Estimated completion is 2002-10.

What interventions are being tested in trial NCT00032994?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00032994?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00032994's enrollment target sits among peer trials

422 886th of 2000 higher than 1,111 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04763356 · 422 participants · NA

    Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

  • NCT06837246 · 422 participants · NA

    A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

  • NCT07298967 · 422 participants · NA

    ORCHARDS-AIR Study

  • NCT06935591 · 423 participants · NA

    Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00032994, the US trial registry maintained by the National Library of Medicine. NCT00032994 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.